Anderson Mori & Tomotsune has a long history of advising international and Japanese health care and life sciences clients on IP acquisition and utilization. We also provide advice in other substantive legal areas, including pharmaceutical regulations (e.g., the Pharmaceutical and Medical Device Act and the Chemical Substances Act). We also conduct due diligence investigations both as part of stand-alone health care and life sciences transactions and as part of larger M&A transactions. Our health care and life sciences attorneys are engaged in proactively assisting clients in the drafting and negotiation of contracts, taking into consideration the uniqueness of the health care and life sciences industries and the nuances of Japanese practice.
'%3e%3cpath%20d='M22.2234%200H1.77187C0.792187%200%200%200.773438%200%201.72969V22.2656C0%2023.2219%200.792187%2024%201.77187%2024H22.2234C23.2031%2024%2024%2023.2219%2024%2022.2703V1.72969C24%200.773438%2023.2031%200%2022.2234%200ZM7.12031%2020.4516H3.55781V8.99531H7.12031V20.4516ZM5.33906%207.43438C4.19531%207.43438%203.27188%206.51094%203.27188%205.37187C3.27188%204.23281%204.19531%203.30937%205.33906%203.30937C6.47813%203.30937%207.40156%204.23281%207.40156%205.37187C7.40156%206.50625%206.47813%207.43438%205.33906%207.43438ZM20.4516%2020.4516H16.8937V14.8828C16.8937%2013.5562%2016.8703%2011.8453%2015.0422%2011.8453C13.1906%2011.8453%2012.9094%2013.2937%2012.9094%2014.7891V20.4516H9.35625V8.99531H12.7687V10.5609H12.8156C13.2891%209.66094%2014.4516%208.70938%2016.1813%208.70938C19.7859%208.70938%2020.4516%2011.0813%2020.4516%2014.1656V20.4516Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_583_3324'%3e%3crect%20width='24'%20height='24'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
